斯芬戈-1-酸盐受体2的概述:结构,生物功能和小分子调节器
Wanting Hao1, Dongdong Luo1, Yuqi Jiang1
1Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Medicinal research reviews
|April 26, 2024
概括
斯芬哥辛-1-酸盐受体2 (S1PR2) 在疾病中起着关键作用. 本综述详细介绍了S1PR2的功能,其调节剂以及多发性硬化症和癌症等疾病的未来治疗发展.
科学领域:
- 生物化学和药理学 生物化学和药理学
- 细胞生物学 细胞生物学
- 药用化学 医学化学
背景情况:
- 氨酸-1-酸盐受体2 (S1PR2),是一种G蛋白结合受体,越来越多地研究其参与各种生理和病理过程.
- S1PR2的激活触发了包括PI3K,MAPK和Rho/ROCK在内的信号通路,影响了与多发性硬化症,纤维化,炎症和瘤相关的功能.
研究的目的:
- 提供关于基-1-酸盐受体2 (S1PR2) 功能及其调节器的全面概述.
- 总结S1PR2在人类疾病中的结构,生物作用和病理意义.
- 审查S1PR2调节器的发现,设计,开发和应用.
主要方法:
- 文献综述和对S1PR2.2现有研究的综合.
- 对S1PR2激活下游的信号通路的分析.
- 检查制药公司和学术机构开发的S1PR2调节器.
主要成果:
- 由于S1PR2与各种疾病有关,因此需要开发向调节器.
- 已经确定了许多S1PR2激动剂和抗剂,具有治疗应用的潜力.
- 该审查整合了关于S1PR2结构,功能,疾病角色和调节器发展的信息.
结论:
- 更深入地了解S1PR2生物学和调节器对于推进疾病治疗至关重要.
- 本综述强调了S1PR2研究和药物开发的挑战和未来方向.
- 有效的S1PR2调节器有望改善各种人类疾病的诊断和治疗.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Amplifying Signals via Second Messengers
6.9K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.9K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
What are Second Messengers?
83.6K
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
83.6K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K


